Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 3008

BillFederalHouseIn Committee
To amend the Federal Food, Drug, and Cosmetic Act to provide for notification by manufacturers of critical essential medicines of increased demand of such drugs, and for other purposes.
About This Bill
Committee
Latest Action · May 5, 2023
Referred to the Subcommittee on Health.
Introduced
April 28, 2023
Cosponsors (49)
47D 2R
View PDF ↗
SummaryFull TextCommentsAnnotations

Full Text

The official full text of this bill isn’t available inside AllCiv yet. Read it on Congress.gov:

A plain-language summary is on the Summary tab — you can highlight and annotate it there.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.